243 related articles for article (PubMed ID: 30587868)
1. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma.
Heianna J; Makino W; Hirakawa H; Yamashita Y; Tomita H; Murayama S
Int J Oral Maxillofac Surg; 2022 Sep; 51(9):1123-1130. PubMed ID: 34955352
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.
Suzuki-Shibata S; Yamamoto Y; Yoshida T; Mizoguchi N; Nonaka T; Kubota A; Narimatsu H; Miyagi Y; Kobayashi T; Kaneta T; Inoue T
Jpn J Radiol; 2017 Dec; 35(12):740-747. PubMed ID: 29039110
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.
Nakamura T; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takayama K; Fuwa N
Jpn J Clin Oncol; 2016 Jan; 46(1):46-50. PubMed ID: 26538461
[TBL] [Abstract][Full Text] [Related]
7. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
[TBL] [Abstract][Full Text] [Related]
8. SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancer.
Doi H; Kitajima K; Fukushima K; Kawanaka Y; Mouri M; Yamamoto S; Ishikura R; Terada T; Noguchi K; Hirota S
Jpn J Radiol; 2016 May; 34(5):349-55. PubMed ID: 26920841
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemotherapy and radiation therapy for squamous cell carcinoma of the maxillary sinus.
Isobe K; Uno T; Hanazawa T; Kawakami H; Yamamoto S; Suzuki H; Iida Y; Ueno N; Okamoto Y; Ito H
Jpn J Clin Oncol; 2005 Nov; 35(11):633-8. PubMed ID: 16275677
[TBL] [Abstract][Full Text] [Related]
10. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
11. [A case of a 91-year-old woman with maxillary sinus carcinoma who achieved a complete response to chemoradiotherapy with intra-arterial administration of docetaxel].
Watanabe A; Taniguchi M; Kawabori S
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1941-3. PubMed ID: 14650963
[TBL] [Abstract][Full Text] [Related]
12. Imaging predictor of ophthalmic involvement in maxillary sinus cancer during super selective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT).
Ashida H; Igarashi T; Nozawa Y; Munetomo Y; Higuchi T; Yamauchi H; Baba A; Abe Y; Shimura E; Kessoku H; Nishiya Y; Kojima H; Ojiri H
Head Face Med; 2021 Aug; 17(1):34. PubMed ID: 34399796
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy in trimodal combination therapy of maxillary sinus squamous cell carcinoma].
Maehara Y; Sakaino K; Nozaki M; Matsumoto M; Satake B; Makino S; Matsuura S
Gan No Rinsho; 1985 Jul; 31(8):901-7. PubMed ID: 3928947
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase expression as a predictor of clinical response to 5-fluorouracil-based chemoradiotherapy in patients with maxillary sinus squamous cell carcinoma.
Yasumatsu R; Nakashima T; Yamauchi M; Wakasaki T; Masuda M; Komune S
Auris Nasus Larynx; 2011 Jun; 38(3):387-91. PubMed ID: 21035287
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the maxillary sinus: the role of radiotherapy.
Sakata K; Akanuma A; Aoki Y; Karasawa K; Nakagawa K; Iio M
Radiat Med; 1989; 7(6):293-7. PubMed ID: 2633217
[TBL] [Abstract][Full Text] [Related]
16. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.
Homma A; Onimaru R; Matsuura K; Shinomiya H; Sakashita T; Shiga K; Tachibana H; Nakamura K; Mizusawa J; Kitahara H; Eba J; Fukuda H; Fujii M; Hayashi R
Head Neck; 2018 Mar; 40(3):475-484. PubMed ID: 29130565
[TBL] [Abstract][Full Text] [Related]
17. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
18. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Jeong Y; Kim JH; Kim SB; Yoon DH; Park SI; Kim YH; Kim HR; Jung HY; Lee GH; Ryu JS
J Surg Oncol; 2014 Apr; 109(5):472-7. PubMed ID: 24301552
[TBL] [Abstract][Full Text] [Related]
19. Utility of
Arnett ALH; Merrell KW; Macintosh EM; James SE; Nathan MA; Shen KR; Ravi K; Neben Wittich MA; Haddock MG; Hallemeier CL
J Thorac Oncol; 2017 Jan; 12(1):121-128. PubMed ID: 27569732
[TBL] [Abstract][Full Text] [Related]
20. The Importance of Concurrent Chemotherapy for T1 Esophageal Cancer: Role of FDG-PET/CT for Local Control.
Ogino I; Watanabe S; Hirasawa K; Misumi T; Hata M; Kunisaki C
In Vivo; 2018; 32(5):1269-1274. PubMed ID: 30150456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
